Home
PBYI
PBYI News

Latest Puma Biotechnology Inc (PBYI) News on November 18, 2024

We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative

Simply Wall St.

4 days ago

We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative

Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

9 days ago

Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations

PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up

Zacks

9 days ago

PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up

GuruFocus.com

10 days ago

Puma Biotechnology Inc (PBYI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

Associated Press Finance

10 days ago

Puma Biotech: Q3 Earnings Snapshot

Puma Biotechnology Reports Third Quarter 2024 Financial Results

Business Wire

10 days ago

Puma Biotechnology Reports Third Quarter 2024 Financial Results

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

12 days ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

3 US Penny Stocks With Market Caps Under $700M

Simply Wall St.

20 days ago

3 US Penny Stocks With Market Caps Under $700M

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

Business Wire

24 days ago

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well?

Simply Wall St.

a month ago

With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well?

Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 79% if they invested five years ago

Simply Wall St.

2 months ago

Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 79% if they invested five years ago

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Business Wire

2 months ago

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

MT Newswires

3 months ago

Federal Judge Rejects Patent Claims Supporting Puma Biotechnology's Breast Cancer Drug; Company Shares Down After Hours

Puma Biotechnology's (NASDAQ:PBYI) Earnings Offer More Than Meets The Eye

Simply Wall St.

3 months ago

Puma Biotechnology's (NASDAQ:PBYI) Earnings Offer More Than Meets The Eye

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

3 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations

Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report

Simply Wall St.

3 months ago

Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected

Zacks

4 months ago

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected

Zacks.com featured highlights Abercrombie & Fitch, Puma Biotechnology, Spotify and Oddity

Zacks

4 months ago

Zacks.com featured highlights Abercrombie & Fitch, Puma Biotechnology, Spotify and Oddity

Associated Press Finance

4 months ago

Puma Biotech: Q2 Earnings Snapshot

Puma Biotechnology Reports Second Quarter Financial Results

Business Wire

4 months ago

Puma Biotechnology Reports Second Quarter Financial Results

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Zacks

4 months ago

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results

Business Wire

4 months ago

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

5 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

5 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

5 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

5 months ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

5 months ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

5 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

5 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

5 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

5 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

5 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer

Business Wire

5 months ago

Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer

Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)

Business Wire

6 months ago

Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)

Puma Biotechnology to Join Russell 3000 Index

Business Wire

6 months ago

Puma Biotechnology to Join Russell 3000 Index

With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors

Simply Wall St.

6 months ago

With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors

Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why

Zacks

6 months ago

Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why

Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting

Business Wire

6 months ago

Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting

Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options

Zacks

6 months ago

Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options

Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results

Simply Wall St.

6 months ago

Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results

Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

6 months ago

Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript

Insider Monkey

6 months ago

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript

Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat

Zacks

6 months ago

Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat

GuruFocus.com

6 months ago

Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...

Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts

GuruFocus.com

7 months ago

Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts

Associated Press Finance

7 months ago

Puma Biotech: Q1 Earnings Snapshot

Puma Biotechnology Reports First Quarter Financial Results

Business Wire

7 months ago

Puma Biotechnology Reports First Quarter Financial Results

Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?

Simply Wall St.

7 months ago

Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?

What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?

Zacks

7 months ago

What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results

Business Wire

7 months ago

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results

Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year

Simply Wall St.

7 months ago

Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

7 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?

Zacks

8 months ago

Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?

Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?

Simply Wall St.

8 months ago

Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?

Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer

Business Wire

8 months ago

Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer

FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study

Zacks

8 months ago

FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study

J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer

Zacks

8 months ago

J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value Estimate

Simply Wall St.

9 months ago

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value Estimate

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Puma Biotechnology Inc Earnings Call

Why Puma Biotech (PBYI) is a Top Value Stock for the Long-Term

Zacks

9 months ago

Why Puma Biotech (PBYI) is a Top Value Stock for the Long-Term

Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates

Zacks

9 months ago

Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates

Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates

Zacks

9 months ago

Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates

Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023

GuruFocus.com

9 months ago

Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023

Associated Press Finance

9 months ago

Puma Biotech: Q4 Earnings Snapshot

Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire

9 months ago

Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results

Sarepta (SRPT) Q4 Earnings Beat Estimates, Revenues Up Y/Y

Zacks

9 months ago

Sarepta (SRPT) Q4 Earnings Beat Estimates, Revenues Up Y/Y

Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat

Zacks

9 months ago

Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

9 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Rocket (RCKT) Registers Narrower-Than-Expected Loss in Q4

Zacks

9 months ago

Rocket (RCKT) Registers Narrower-Than-Expected Loss in Q4

Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?

Zacks

9 months ago

Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?

Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference

Business Wire

9 months ago

Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference

United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates

Zacks

9 months ago

United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates

AbbVie (ABBV) Announces Appointment of New CEO Robert Michael

Zacks

9 months ago

AbbVie (ABBV) Announces Appointment of New CEO Robert Michael

Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod

Zacks

9 months ago

Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod

Iovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi

Zacks

9 months ago

Iovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results

Business Wire

9 months ago

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results

Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology

Zacks

9 months ago

Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology

Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer

Business Wire

9 months ago

Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer

Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma

Zacks

9 months ago

Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma

Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up

Zacks

9 months ago

Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up

Merck (MRK) Unit to Buy Elanco's Aqua Business for $1.3B

Zacks

9 months ago

Merck (MRK) Unit to Buy Elanco's Aqua Business for $1.3B

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B

Zacks

9 months ago

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B

Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why

Zacks

9 months ago

Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why

Civeo Announces Quarterly Dividend

Business Wire

10 months ago

Civeo Announces Quarterly Dividend

Rainbow Realty Group Announces Launch of Fund IV: Capitalizing on a Moment in Time

PR Newswire

10 months ago

Rainbow Realty Group Announces Launch of Fund IV: Capitalizing on a Moment in Time

3 Strong Buy Stocks Under $5: January 2024

InvestorPlace

10 months ago

3 Strong Buy Stocks Under $5: January 2024

Bristol Myers' (BMY) sBLAs for Breyanzi Get FDA Priority Tag

Zacks

10 months ago

Bristol Myers' (BMY) sBLAs for Breyanzi Get FDA Priority Tag

2seventy bio (TSVT) Divests R&D Assets to Regeneron, Stock Up

Zacks

10 months ago

2seventy bio (TSVT) Divests R&D Assets to Regeneron, Stock Up

Amwell to Report Fourth Quarter and Full Year 2023 Operating Results on Feb. 14

GlobeNewswire

10 months ago

Amwell to Report Fourth Quarter and Full Year 2023 Operating Results on Feb. 14

First Business Bank Announces 10% Increase in Quarterly Common Stock Dividend

Business Wire

10 months ago

First Business Bank Announces 10% Increase in Quarterly Common Stock Dividend

Invesco Closed-End Funds Declare Dividends

PR Newswire

10 months ago

Invesco Closed-End Funds Declare Dividends

GuruFocus.com

10 months ago

Sierra Bancorp (BSRR) Reports Year-End Earnings, Emphasizes Strategic Growth Amidst Challenges

GlobeNewswire

10 months ago

F&M Bank Signs Atlanta Braves’ Kade Kern to Brand Partnership

Associated Press Finance

10 months ago

Sierra Bancorp: Q4 Earnings Snapshot

Sierra Bancorp Reports Strategic Securities Transaction as Well as Fourth Quarter and Year End 2023 Results

Business Wire

10 months ago

Sierra Bancorp Reports Strategic Securities Transaction as Well as Fourth Quarter and Year End 2023 Results

Associated Press Finance

10 months ago

Financial Institutions: Q4 Earnings Snapshot

Trump-South Carolina: Does He Own Any Property in The Palmetto State?

Benzinga

10 months ago

Trump-South Carolina: Does He Own Any Property in The Palmetto State?

ACCESSWIRE

10 months ago

HSN Champions Emerging Designers Through Exclusive Collaboration With Harlem's Fashion Row

Share on Social Networks: